Home > Insider Trading > Filing (0001209191-15-079482)

Filing Details

Accession Number:: 0001209191-15-079482
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-11-12 07:35:47
Reporting Period:: 2015-11-11

Filing Date:: 2015-11-12
Accepted Time:: 2015-11-12 07:35:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1593034	Endo International Plc	ENDP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1533149	Suketu Upadhyay	C/O Endo International Plc First Fl, Minerva House, Simmonscourt Rd Ballsbridge, Dublin 4 L2	Evp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2015-11-11	1,000	$55.31	12,436	No	4	P	Direct
Ordinary Shares	Acquisiton	2015-11-11	3,450	$56.68	15,886	No	4	P	Direct
Stock Incentive Plan Performance Shares	Acquisiton	2015-11-11	4,450	$0.00	51,310	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Stock Incentive Plan Restricted Stock Units (Rsu)	17,740	Direct

Footnotes

This represents the average price per share of ordinary shares that Mr. Upadhyay bought on the open market on November 11, 2015 at prices ranging from $55.00 to $55.70.
This represents the average price per share of ordinary shares that Mr. Upadhyay bought on the open market on November 11, 2015 at prices ranging from $56.21 to $57.01.
The performance shares vest upon the Company achieving certain shareholder return targets over a cumulative 3-year period.
Represents the target number of shares issuable upon achievement of a certain shareholder return target over a cumulative 3-year period, asdetermined by the Registrant's Board of Directors at the end of such three-year period. The ultimate number of shares issued may be the targetnumber or zero, depending on the Registrant's attainment of the shareholder return target over the period.
Pursuant to the Endo International plc Matched Performance Share Unit Program, the Registrant matched Mr. Upadhyay's open market purchases of ordinary shares, subject to certain limitations, which occurred on November 11, 2015, as reported above. These securities were granted to Mr. Upadhyay in consideration of his services as the Executive Vice President and Chief Financial Officer of Endo International plc.
Represents the cumulative target quantity of shares issuable with respect to all 2010 and 2015 Stock Incentive Plan performance sharesoutstanding. The cumulative total is the combination of the target payouts for the current grant and all past grants made under the 2010 StockIncentive Plan and the 2015 Stock Incentive Plan and still outstanding, which are subject to a range of payouts depending on the achievement ofcertain performance metrics as described herein for the current grant and as previously disclosed for all other performance share grants.
Subject to time-based vesting, each restricted stock automatically converts into one (1) ordinary share of Endo International plc.